Check out our most popular compounded medications! Get Started
The Dexamethasone 0.4%/Lidocaine HCL 2% Iontophoresis Liquid is a specialized formulation designed for use in iontophoresis therapy. This technique employs an electric current to enhance the transdermal delivery of the medication directly into the affected area.
Dexamethasone is utilized for its anti-inflammatory properties, which can help reduce swelling and pain associated with various conditions. Lidocaine provides immediate topical analgesic effects, offering relief from pain by numbing the treated area. Together, these agents work synergistically to manage symptoms and provide therapeutic benefits.
This iontophoresis liquid is primarily indicated for the treatment of localized musculoskeletal conditions. It is commonly used to alleviate pain and inflammation associated with conditions such as tendonitis, bursitis, and arthritis. Additionally, it may be employed in the management of localized edema and in the treatment of certain types of soft tissue injuries. The precise delivery of medication through iontophoresis ensures that the treatment is concentrated in the area where it is most needed, potentially reducing systemic side effects and improving patient outcomes.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The Dexamethasone 0.4%/Lidocaine HCL 2% Iontophoresis Liquid is a cutting-edge formulation designed for use in iontophoresis, a non-invasive method to deliver medication directly into the skin using a mild electrical current. This specialized liquid formulation combines the potent anti-inflammatory and immunosuppressive effects of Dexamethasone with the local anesthetic properties of Lidocaine HCL.
Dexamethasone is a synthetic corticosteroid with powerful anti-inflammatory capabilities. It works by inhibiting the release of substances in the body that cause inflammation, thereby reducing swelling, redness, and pain in the targeted area. This makes it particularly useful in treating inflammatory conditions such as bursitis, tendonitis, and certain types of arthritis. When delivered through iontophoresis, Dexamethasone can exert its effects directly at the site of inflammation, minimizing systemic exposure and potential side effects.
Lidocaine HCL is a well-known local anesthetic that provides temporary relief of pain by blocking nerve signals in the body. When used in conjunction with Dexamethasone in iontophoresis, Lidocaine HCL can provide immediate pain relief in the targeted area while the anti-inflammatory effects of Dexamethasone develop. This dual-action approach can be particularly beneficial for patients suffering from acute or chronic pain due to musculoskeletal disorders.
The combination of these two medications in an iontophoresis liquid allows for a focused approach to treatment, delivering the drugs directly to the affected tissues. This localized delivery system can result in fewer systemic side effects compared to oral or systemic administration, and can be particularly advantageous for patients who may have contraindications to systemic corticosteroid or anesthetic use.
For prescribers considering this formulation for their patients, it is important to note that the effectiveness of iontophoresis can vary based on individual patient factors, the condition being treated, and the specific protocol used (such as current strength and duration of treatment). It is also essential to ensure that the patient is a suitable candidate for iontophoresis and to provide them with comprehensive instructions on the procedure.
Patients should be informed that the sensation of the electrical current during iontophoresis is generally well-tolerated, and they may experience immediate pain relief due to the Lidocaine component. They should also be advised on the potential side effects, which may include skin irritation at the site of electrode placement. Continuous monitoring and follow-up are recommended to assess the efficacy of the treatment and to make any necessary adjustments.
If you have any questions or require further information about the Dexamethasone 0.4%/Lidocaine HCL 2% Iontophoresis Liquid formulation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing support and guidance to both patients and healthcare providers to ensure the safe and appropriate use of this specialized treatment option.
The Dexamethasone 0.4%/Lidocaine HCL 2% Iontophoresis Liquid is a specialized formulation designed for use in iontophoresis therapy. This therapy utilizes an electric current to enhance the transdermal delivery of the medication, targeting specific areas for treatment. Dexamethasone is a corticosteroid with anti-inflammatory and immunosuppressant properties, making it useful in treating various inflammatory conditions. Lidocaine is a local anesthetic that provides temporary relief of pain by blocking nerve signals in the body.
When considering drug interactions, it is important to note that both dexamethasone and lidocaine have the potential to interact with other medications. Dexamethasone may interact with drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs), which could increase the risk of gastrointestinal side effects. It may also reduce the effects of diabetes medications, necessitating adjustments in dosing. Additionally, dexamethasone can interact with certain blood thinners, seizure medications, and vaccines.
Lidocaine, on the other hand, may interact with antiarrhythmic drugs, beta-blockers, and other local anesthetics. Caution is advised when using this formulation in patients taking medications that affect cardiac conduction or those with pre-existing heart conditions. The concurrent use of other CNS depressants, such as opioids or benzodiazepines, with lidocaine may increase the risk of CNS side effects like drowsiness or dizziness.
It is also important to consider the potential for additive systemic absorption when using iontophoresis, although the risk is generally low due to the localized nature of the treatment. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs, supplements, and herbal products, to assess for any potential interactions.
Patients with certain medical conditions, such as liver or kidney disease, heart conditions, or a history of seizures, should use this formulation with caution, as these conditions may affect the metabolism and excretion of the drugs, potentially leading to increased side effects or toxicity.
For prescribers, it is crucial to evaluate the patient's complete medication profile and medical history to ensure the safe use of this iontophoresis liquid formulation. Monitoring for therapeutic efficacy and adverse effects should be conducted regularly. If you have any questions or require further information regarding this formulation and its potential drug interactions, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the necessary support and guidance.
The Dexamethasone 0.4%/Lidocaine HCL 2% Iontophoresis Liquid is a specialized formulation designed for use in iontophoresis therapy, a non-invasive method to deliver medication through the skin using a low-level electrical current. This technique enhances the penetration of the drugs into the targeted tissue, providing localized treatment while minimizing systemic exposure and potential side effects.
Dexamethasone is a potent corticosteroid with anti-inflammatory and immunosuppressant properties. When delivered via iontophoresis, dexamethasone can reduce inflammation and alleviate pain in localized areas. The localized effect of dexamethasone through iontophoresis ensures that the medication is concentrated at the site of inflammation, providing relief where it is most needed without the systemic effects that oral or parenteral administration might cause.
Lidocaine HCL is a local anesthetic that works by blocking nerve signals in the body. When used in conjunction with dexamethasone in iontophoresis, lidocaine provides immediate pain relief by numbing the targeted area. This can be particularly beneficial for patients experiencing acute pain or for those who require pain management during rehabilitation exercises. The addition of lidocaine to the formulation allows for a more comfortable treatment experience and can help to reduce the discomfort associated with the underlying condition being treated.
The combination of dexamethasone and lidocaine in an iontophoresis liquid formulation offers a synergistic effect, with the anti-inflammatory action of dexamethasone complemented by the analgesic properties of lidocaine. This dual-action approach can lead to improved patient outcomes, especially in the management of localized pain and inflammation. The use of iontophoresis ensures that the medication is delivered directly to the affected area, increasing the concentration of the drug at the site of pathology while reducing systemic absorption.
For patients and prescribers considering this formulation, it is important to understand that the success of iontophoresis therapy depends on several factors, including the correct application of the iontophoresis device, the duration and intensity of the electrical current, and the specific condition being treated. It is also essential to follow the recommended guidelines for use and to monitor the patient's response to therapy. If you have any questions or require further information about the Dexamethasone 0.4%/Lidocaine HCL 2% Iontophoresis Liquid, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide support and guidance to ensure the safe and appropriate use of this formulation.
Iontophoresis is a technique that uses a small electric current to drive medications, such as Dexamethasone and Lidocaine, through the skin and into underlying tissues. The current helps to increase the skin's permeability, allowing the medication to reach the target area more effectively for therapeutic purposes.
This compounded formulation is commonly used to treat conditions that benefit from anti-inflammatory or analgesic drugs, such as localized pain, inflammation, or swelling. It can be particularly useful in treating conditions like tendinitis, bursitis, or arthritis.
The frequency of iontophoresis treatments can vary depending on the individual case and should be determined by a healthcare provider. Treatments can range from daily to several times a week, depending on the condition being treated and how a patient responds to therapy.
While iontophoresis is a relatively safe treatment, some individuals may experience minor skin irritation, redness, or a burning sensation at the treatment site. Allergic reactions to the medications are possible, though rare. If you experience any severe side effects, you should discontinue use and consult a healthcare professional.
While many people can benefit from iontophoresis, there are certain circumstances where it may not be advised. Patients with pacemakers, those who are pregnant, or individuals with a history of heart problems or epilepsy should consult with a healthcare provider before starting treatment. Additionally, iontophoresis should not be used on damaged or broken skin.
It’s usually recommended to clean the treatment area thoroughly to remove any barriers such as oils or dead skin that could impede medication absorption. Your healthcare provider will give you specific instructions based on the body part being treated and your individual care plan.
Yes, a specialized iontophoresis device is required to apply the electric current that facilitates the transdermal delivery of the Dexamethasone/Lidocaine Iontophoresis liquid. These devices are typically provided by a healthcare practitioner or obtained through a medical supply company with a prescription.
While iontophoresis can be performed at home with a portable device and proper training, it is important to first consult with a healthcare professional to learn the correct technique and to receive a tailored treatment regimen. Some patients may receive their initial treatments in a clinical setting before transitioning to home treatment.
Iontophoresis sessions typically last between 10 to 20 minutes, depending on the condition being treated and the specific protocol provided by the healthcare provider. The duration may be adjusted based on the patient's response to treatment and level of comfort.
The compounded Dexamethasone/Lidocaine liquid should be stored according to the manufacturer's or compounding pharmacy's instructions, typically in a cool, dry place away from direct sunlight. Always check the expiration date before use, and ensure the bottle is sealed tightly after each use to maintain the medication's integrity.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
